The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies
出版年份 2018 全文链接
标题
The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies
作者
关键词
-
出版物
Cancers
Volume 10, Issue 4, Pages 104
出版商
MDPI AG
发表日期
2018-04-04
DOI
10.3390/cancers10040104
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- (2018) Shuichiro Takahashi et al. BLOOD
- The microbiome and systemic lupus erythematosus
- (2017) Nurit Katz-Agranov et al. IMMUNOLOGIC RESEARCH
- Impact of inflammation on early hematopoiesis and the microenvironment
- (2017) Hitoshi Takizawa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Inflammation and myeloproliferative neoplasms
- (2017) Federico Lussana et al. JOURNAL OF AUTOIMMUNITY
- Obesity alters the long-term fitness of the hematopoietic stem cell compartment through modulation ofGfi1expression
- (2017) Jung-Mi Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders
- (2017) Daniel C. McFarland et al. Journal of the National Comprehensive Cancer Network
- Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms
- (2017) Jie Zhang et al. JOURNAL OF THEORETICAL BIOLOGY
- Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study
- (2017) Nancy K Gillis et al. LANCET ONCOLOGY
- Cytokines in Autoimmune Disease
- (2017) Qingdong Guan et al. MEDIATORS OF INFLAMMATION
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microbiome, inflammation and colorectal cancer
- (2017) Ju Chen et al. SEMINARS IN IMMUNOLOGY
- Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib
- (2017) Mads Emil Bjørn et al. Expert Review of Hematology
- Familial Mediterranean Fever and Incidence of Cancer
- (2017) Ronen Brenner et al. Arthritis & Rheumatology
- Role of Gut Microbiota in Rheumatoid Arthritis
- (2017) Yuichi Maeda et al. Journal of Clinical Medicine
- Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
- (2017) Morten Andersen et al. PLoS One
- Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis
- (2017) Shufen Li et al. Scientific Reports
- Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota
- (2016) Kamilla S. Josefsdottir et al. BLOOD
- Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
- (2016) D. A. Hinds et al. BLOOD
- Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy
- (2016) Julia L Drewes et al. BRITISH JOURNAL OF CANCER
- Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?
- (2016) Q Chen et al. CELL DEATH AND DIFFERENTIATION
- Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
- (2016) John O. Mascarenhas et al. HAEMATOLOGICA
- TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy
- (2016) E Nievergall et al. LEUKEMIA
- Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
- (2016) S Koschmieder et al. LEUKEMIA
- Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?
- (2016) Mette Vestergaard Elbæk et al. LEUKEMIA & LYMPHOMA
- Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms
- (2016) Anders Lindholm Sørensen et al. LEUKEMIA RESEARCH
- DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
- (2016) Olga A Guryanova et al. NATURE MEDICINE
- Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation
- (2016) Katie A. Matatall et al. Cell Reports
- Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
- (2016) John O. Mascarenhas et al. HAEMATOLOGICA
- Sepsis Induces Hematopoietic Stem Cell Exhaustion and Myelosuppression through Distinct Contributions of TRIF and MYD88
- (2016) Huajia Zhang et al. Stem Cell Reports
- Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment
- (2016) Larisa V. Kovtonyuk et al. Frontiers in Immunology
- Human and Murine Hematopoietic Stem Cell Aging Is Associated with Functional Impairments and Intrinsic Megakaryocytic/Erythroid Bias
- (2016) Alexandra Rundberg Nilsson et al. PLoS One
- Ropeginterferon alfa-2b, a novel IFN -2b, induces high response rates with low toxicity in patients with polycythemia vera
- (2015) H. Gisslinger et al. BLOOD
- Smoking and philadelphia-negative chronic myeloproliferative neoplasms
- (2015) Anders Lindholm Sørensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
- (2015) Cecilie Utke Rank et al. LEUKEMIA & LYMPHOMA
- Smoking as a contributing factor for development of polycythemia vera and related neoplasms
- (2015) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis
- (2015) Christophe Desterke et al. MEDIATORS OF INFLAMMATION
- Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
- (2015) Holly L. Geyer et al. MEDIATORS OF INFLAMMATION
- Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
- (2015) Gregor Hoermann et al. MEDIATORS OF INFLAMMATION
- MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
- (2015) Hans Carl Hasselbalch et al. MEDIATORS OF INFLAMMATION
- Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response
- (2015) Marco Pizzi et al. MODERN PATHOLOGY
- Targeting JAK kinase in solid tumors: emerging opportunities and challenges
- (2015) M Buchert et al. ONCOGENE
- JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
- (2015) M. Kleppe et al. Cancer Discovery
- Leukemic transformation in myeloproliferative neoplasms: Therapy-related or unrelated?
- (2014) Magnus Björkholm et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- Bone marrow fat accumulation accelerated by high fat diet is suppressed by exercise
- (2014) Maya Styner et al. BONE
- Gut Microbiota Promote Hematopoiesis to Control Bacterial Infection
- (2014) Arya Khosravi et al. Cell Host & Microbe
- Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications
- (2014) Emmanuel Pourcelot et al. EXPERIMENTAL HEMATOLOGY
- Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature
- (2014) Maria E. Vergara-Lluri et al. HUMAN PATHOLOGY
- Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia
- (2014) Bruno Cassinat et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
- (2014) Leeyen Hsu et al. Journal of Immunology Research
- Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon- in a murine model of polycythemia vera
- (2013) A. Mullally et al. BLOOD
- Proliferation-Dependent Alterations of the DNA Methylation Landscape Underlie Hematopoietic Stem Cell Aging
- (2013) Isabel Beerman et al. Cell Stem Cell
- An Update on Autoinflammatory Diseases
- (2013) F. Ciccarelli et al. CURRENT MEDICINAL CHEMISTRY
- Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levels
- (2013) Beatriz Sanchez-Correa et al. CYTOKINE
- Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in The Iowa Women's Health Study cohort
- (2013) Alexis D. Leal et al. INTERNATIONAL JOURNAL OF CANCER
- Differential regulation of myeloid leukemias by the bone marrow microenvironment
- (2013) Daniela S Krause et al. NATURE MEDICINE
- Chronic TLR Signaling Impairs the Long-Term Repopulating Potential of Hematopoietic Stem Cells of Wild Type but Not Id1 Deficient Mice
- (2013) Ying Zhao et al. PLoS One
- Lifestyle Factors and Inflammation: Associations by Body Mass Index
- (2013) Elizabeth D. Kantor et al. PLoS One
- Maladies auto-immunes et cancers. Première partie : cancers au cours des maladies auto-immunes et de leur traitement
- (2013) F. Pasquet et al. REVUE DE MEDECINE INTERNE
- Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
- (2013) Richard T Silver et al. Expert Review of Hematology
- Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
- (2012) Rakhee Vaidya et al. AMERICAN JOURNAL OF HEMATOLOGY
- Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
- (2012) Robyn M. Emanuel et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia
- (2012) Filgen Y. Fung et al. LEUKEMIA RESEARCH
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK/STAT signaling in hematological malignancies
- (2012) W Vainchenker et al. ONCOGENE
- TNF facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
- (2011) A. G. Fleischman et al. BLOOD
- Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes
- (2011) A. Krings et al. BONE
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
- (2011) Kelly Moran-Crusio et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?
- (2011) S. Hermouet et al. HAEMATOLOGICA
- Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
- (2011) Sigurdur Y. Kristinsson et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic Exposure to a TLR Ligand Injures Hematopoietic Stem Cells
- (2011) B. L. Esplin et al. JOURNAL OF IMMUNOLOGY
- The Symptom Burden of Patients with Hematological Malignancy: A Cross-Sectional Observational Study
- (2011) Vanessa Manitta et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Dnmt3a is essential for hematopoietic stem cell differentiation
- (2011) Grant A Challen et al. NATURE GENETICS
- Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
- (2011) W. W. Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autoimmunity and the risk of myeloproliferative neoplasms
- (2010) S. Y. Kristinsson et al. HAEMATOLOGICA
- Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes
- (2010) X. Feng et al. HAEMATOLOGICA
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
- (2010) Marc H. G. P. Raaijmakers et al. NATURE
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F
- (2010) M Boissinot et al. ONCOGENE
- Risks of myeloid malignancies in patients with autoimmune conditions
- (2009) L A Anderson et al. BRITISH JOURNAL OF CANCER
- Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis
- (2009) Ruben A. Mesa et al. LEUKEMIA RESEARCH
- A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
- (2009) Outi Kilpivaara et al. NATURE GENETICS
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
- (2009) Amy V Jones et al. NATURE GENETICS
- Genome-wide association study identifies eight loci associated with blood pressure
- (2009) Christopher Newton-Cheh et al. NATURE GENETICS
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
- (2008) K. Ekstrom Smedby et al. BLOOD
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
- (2008) Jeffrey C Barrett et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started